Improving the clinical value and utility of CGM systems: issues and recommendations

[1]  L. Dimeglio,et al.  Type 1 Diabetes , 2019, Epidemiology of Diabetes.

[2]  L. Heinemann,et al.  Discrepancies Between Blood Glucose and Interstitial Glucose—Technological Artifacts or Physiology: Implications for Selection of the Appropriate Therapeutic Target , 2017, Journal of diabetes science and technology.

[3]  L. Heinemann,et al.  SPECTRUM: A Training and Treatment Program for Continuous Glucose Monitoring for All Age Groups , 2017 .

[4]  Rodica Pop-Busui,et al.  REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Well-Controlled Adults With Type 1 Diabetes , 2017 .

[5]  Howard Wolpert,et al.  Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial , 2017, JAMA.

[6]  Gerry Rayman,et al.  Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial , 2016, Diabetes Therapy.

[7]  Robert A. Vigersky,et al.  Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes , 2016, Diabetologia.

[8]  P. Geelhoed-Duijvestijn,et al.  Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial , 2016, The Lancet.

[9]  J. Hans DeVries,et al.  Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial , 2016, Diabetes Care.

[10]  J. DeVries,et al.  Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. , 2016, The lancet. Diabetes & endocrinology.

[11]  Bruce W Bode,et al.  Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes. , 2016, JAMA.

[12]  Alison B. Evert,et al.  Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[13]  R. Rabasa-Lhoret,et al.  Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During Exercise. , 2016, Diabetes technology & therapeutics.

[14]  J Hans DeVries,et al.  Continuous Glucose Monitoring , 2016, Journal of diabetes science and technology.

[15]  D. Klonoff,et al.  Now Is the Time for a Cybersecurity Standard for Connected Diabetes Devices , 2016, Journal of diabetes science and technology.

[16]  W. Polonsky,et al.  Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study) , 2016, Journal of diabetes science and technology.

[17]  Joyce M Lee,et al.  A Patient-Designed Do-It-Yourself Mobile Technology System for Diabetes: Promise and Challenges for a New Era in Medicine. , 2016, JAMA.

[18]  S. Edelman,et al.  Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM) , 2016, Journal of diabetes science and technology.

[19]  W. Polonsky,et al.  The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older , 2016, Journal of diabetes science and technology.

[20]  Howard C. Zisser,et al.  Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report , 2016, Diabetes Care.

[21]  Marc D. Breton,et al.  Multinational Home Use of Closed-Loop Control Is Safe and Effective , 2016, Diabetes Care.

[22]  C. Cobelli,et al.  Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes , 2016, Diabetes Care.

[23]  J. Kleijnen,et al.  Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. , 2016, Health technology assessment.

[24]  Bruce W Bode,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[25]  David Rodbard,et al.  Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. , 2016, Diabetes technology & therapeutics.

[26]  S. Edelman,et al.  Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring. , 2016, Diabetes technology & therapeutics.

[27]  L. Heinemann,et al.  IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial , 2016, Journal of diabetes science and technology.

[28]  Guido Freckmann,et al.  CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring , 2015, Journal of diabetes science and technology.

[29]  Darrell M. Wilson,et al.  Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197–1204 , 2015, Diabetes Care.

[30]  B. Wayne Bequette,et al.  Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis , 2015, Diabetes Care.

[31]  T. Kubiak,et al.  Patient-Reported Outcomes and Continuous Glucose Monitoring: Can We Do Better With Artificial Pancreas Devices? , 2015, Diabetes Care.

[32]  G. Alexander Fleming,et al.  Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group , 2015, Diabetologia.

[33]  David M. Maahs,et al.  Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry , 2014, Diabetes Care.

[34]  D. Elbourne,et al.  Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects☆ , 2014, Journal of clinical epidemiology.

[35]  J. Pickup.  The Evidence Base for Diabetes Technology: Appropriate and Inappropriate Meta-Analysis , 2013, Journal of diabetes science and technology.

[36]  T. Jones,et al.  Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. , 2013, JAMA.

[37]  A. M. Kyaw,et al.  Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes , 2013, Diabetology & Metabolic Syndrome.

[38]  D. Klonoff,et al.  Threshold-based insulin-pump interruption for reduction of hypoglycemia. , 2013, The New England journal of medicine.

[39]  D. Klonoff,et al.  Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). , 2013, Diabetes technology & therapeutics.

[40]  J. Hans DeVries,et al.  Reimbursement for Continuous Glucose Monitoring: A European View , 2012, Journal of diabetes science and technology.

[41]  E. Bass,et al.  Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus , 2012, Annals of Internal Medicine.

[42]  Ernest Alema-Mensah,et al.  Comparative Analysis of the Efficacy of Continuous Glucose Monitoring and Self-Monitoring of Blood Glucose in Type 1 Diabetes Mellitus , 2012, Journal of diabetes science and technology.

[43]  E. Bass,et al.  Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness , 2012 .

[44]  Lotty Hooft,et al.  Continuous glucose monitoring systems for type 1 diabetes mellitus. , 2012, The Cochrane database of systematic reviews.

[45]  Stephanie J. Fonda,et al.  Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes , 2011, Diabetes Care.

[46]  D. Klonoff,et al.  Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[47]  Alex J Sutton,et al.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data , 2011, BMJ : British Medical Journal.

[48]  Victor M. Montori,et al.  Efficacy of Continuous Glucose Monitoring in Improving Glycemic Control and Reducing Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Trials , 2011, Journal of diabetes science and technology.

[49]  Stephanie J. Fonda,et al.  The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus , 2011, Journal of diabetes science and technology.

[50]  J. Geddes,et al.  What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.

[51]  Michael O'Grady,et al.  Continuous glucose monitoring and intensive treatment of type 1 diabetes. , 2008, The New England journal of medicine.

[52]  H. J. Yoo,et al.  Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. , 2008, Diabetes research and clinical practice.

[53]  D. Golicki,et al.  Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis , 2008, Diabetologia.

[54]  R. Potts,et al.  Physiological differences between interstitial glucose and blood glucose measured in human subjects. , 2003, Diabetes care.

[55]  W. Tamborlane,et al.  Discrepancies Between Blood Glucose and Glycosylated Hemoglobin in Intensively Treated Diabetic Patients , 1988, The Diabetes educator.